RESUMEN
BACKGROUND: Amplification of the c-myc gene has been reported in non-small cell lung cancer (NSCLC). We investigated the c-myc gene amplification and the numerical aberration of chromosome 8 by dual color fluorescence in situ hybridization (FISH) to evaluate the relation between possible genetic abnormalities, pathological factors and prognosis. METHODS: Tumor tissue samples were obtained from 31 patients with NSCLC who underwent lobectomy with mediastinal lymph node dissection. Samples were analyzed by FISH using 8 alpha satellite DNA probe and c-myc gene cosmid probe. The relation between genetic abnormalities, pathological factors (T factor, tumor size, and N factor), and prognostic factors was evaluated by univariate and multivariate analysis, and by the Kaplan-Meier method and log-rank analysis. RESULTS: Chromosome 8 aberrations were T1 (n=3), 44.0%; T2 (n=18), 35.7%; T3 (n=7), 40.0%; T4 (n=3), 39.7% (p=NS). The c-myc gene amplifications were T1, 54.3%; T2, 51.1%; T3, 51.0%; T4, 66.3% (p=NS). There was no difference between patients whose tumor was more than 5 cm (n=16), and 5 cm or less (n=15) in the rate of chromosome 8 aberration (39.3%: 36.3%), or the rate of the c-myc gene amplification (52.1%: 53.7%). N factors for chromosome 8 aberrations were N0 (n=18), 35.9%; and N2 (n=11), 44.9% (p=NS). In the c-myc gene amplification, there was a significant difference between N0 and N2 (48.6%, 61.3%, p=0.040). In univariate and multivariate analysis, chromosome 8 aberrations correlated with a poor prognosis (p=0.037 and p=0.041). The 5-year survival rate was 15.4% in patients whose rate of chromosome 8 aberrations was 40% or more (n=13), which was significantly less than that in patients with an aberration rate of less than 40% (n=19, 57.9%, p=0.014). CONCLUSION: The c-myc gene amplification correlates with lymph node metastasis. Although there was no significant link between the amplification of the c-myc gene and clinical outcome, the numerical chromosome 8 aberrations was considered to be a factor for survival.
Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/genética , Aberraciones Cromosómicas/mortalidad , Aberraciones Cromosómicas/fisiología , Cromosomas Humanos Par 8/fisiología , Genes myc/fisiología , Neoplasias Pulmonares/genética , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Pulmón de Células no Pequeñas/diagnóstico , Carcinoma de Pulmón de Células no Pequeñas/mortalidad , Trastornos de los Cromosomas , Femenino , Estudios de Seguimiento , Amplificación de Genes/fisiología , Humanos , Hibridación Fluorescente in Situ/métodos , Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/mortalidad , Masculino , Persona de Mediana Edad , Análisis Multivariante , Pronóstico , Tasa de SupervivenciaRESUMEN
The prognostic significance of bone marrow cytogenetic lesions in myelofibrosis with myeloid metaplasia (MMM) was investigated in a retrospective series of 165 patients. An abnormal karyotype was demonstrated in 57% of patients. At diagnosis (n = 92), 48% of the patients had detectable cytogenetic abnormalities, and clonal evolution was frequently demonstrated in sequential studies. More than 90% of the anomalies were represented by 20q-, 13q-, +8, +9, 12p-, and abnormalities of chromosomes 1 and 7. Of these, 20q-, 13q- and +8 were the most frequent sole abnormalities, each occurring in 15-25% of the abnormal cases. Trisomy 9 and abnormalities of chromosomes 1 and 7 were equally prevalent but were usually associated with additional cytogenetic lesions. Chromosome 5 abnormalities were infrequent but were over-represented in the group of patients exposed to genotoxic therapy. In a multivariate analysis that incorporated other clinical and laboratory variables, the presence of an abnormal karyotype did not carry an adverse prognosis. Instead, +8, 12p-, advanced age and anaemia were independent prognostic determinants of inferior survival. In particular, survival was not adversely affected by the presence of either 20q- or 13q-.
Asunto(s)
Aberraciones Cromosómicas/diagnóstico , Cromosomas Humanos Par 1 , Cromosomas Humanos Par 7 , Mielofibrosis Primaria/complicaciones , Mielofibrosis Primaria/genética , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Anemia/complicaciones , Anemia/genética , Aberraciones Cromosómicas/mortalidad , Trastornos de los Cromosomas , Cromosomas Humanos Par 5 , Cromosomas Humanos Par 9 , Femenino , Humanos , Cariotipificación , Masculino , Persona de Mediana Edad , Mielofibrosis Primaria/mortalidad , Pronóstico , Estudios Retrospectivos , Análisis de SupervivenciaRESUMEN
This study of the outcome and prognostic factors in prenatally diagnosed agenesis of the corpus callosum (ACC) was undertaken to see if there are any differences between subgroups, what relationship they have to neurodevelopmental outcome and whether this information aids the counselling of parents of fetuses with the condition. The outcome of 14 prenatally diagnosed fetuses with ACC and 61 postnatally diagnosed patients was assessed in terms of clinical problems, developmental milestones and neurological signs; each patient was then given a score out of 10, 0 being a normal outcome and 10 being the worst outcome, i.e. death or termination of pregnancy. Comparing patients diagnosed pre- and postnatally, several similarities were found indicating that the postnatal group can provide useful information about the prenatal group. There was a higher incidence of ACC in males than females. In the prenatally diagnosed patients complete ACC was more common than partial ACC, although this might be because partial ACC was easily missed. Complete ACC has a worse prognosis than partial ACC (p = 0.001), and when associated with other anomalies, especially of the central nervous system, the outcome is very bad (p < 0.01). The only neurodevelopmentally normal patients were in the isolated partial ACC group. This study highlights the need to perform a detailed review of fetal anatomy and the desirability of determining the karyotype of the fetus in all newly diagnosed cases of ACC so that as much information as possible is available before parents are counselled about the likely outcome.
Asunto(s)
Agenesia del Cuerpo Calloso , Malformaciones del Sistema Nervioso/diagnóstico por imagen , Malformaciones del Sistema Nervioso/mortalidad , Diagnóstico Prenatal/mortalidad , Niño , Aberraciones Cromosómicas/diagnóstico por imagen , Aberraciones Cromosómicas/mortalidad , Trastornos de los Cromosomas , Discapacidades del Desarrollo/diagnóstico por imagen , Discapacidades del Desarrollo/mortalidad , Femenino , Estudios de Seguimiento , Asesoramiento Genético , Humanos , Incidencia , Lactante , Imagen por Resonancia Magnética , Masculino , Valor Predictivo de las Pruebas , Pronóstico , Distribución por Sexo , Tomografía Computarizada por Rayos X , UltrasonografíaRESUMEN
BACKGROUND: Congenital malformations are defined as those structural, metabolic or functional defects found at birth. AIM: To study the mortality due to congenital malformations in Chile between 1969 and 1997, their type, individual, temporal and geographic variations. MATERIAL AND METHODS: A descriptive analysis of deaths registered by the National Statistics Institute and the Ministry of Health. Means, frequencies, raw and adjusted rates were calculated and inferences for some variables were carried out. RESULTS: Between 1969 and 1997 ther was tendency towards a reduction in rates of mortality due to congenital malformations and an increment in their relative importance. During the period, the risk for chromosome (98%) and osteomuscular (67%) malformations increased. Men and children of less than one year had the higher risk. In 1995, 1167 deaths due to congenital malformations were registered, 90% in children of less than 5 years. Higher risks occurred in urban zones (with a rate of 8.25 per 100,000) in the third region (rate 11.59) and second region (rate 11.2). Most deaths occurred in hospitals (85%). Main causes of death were circulatory system, central nervous system and chromosome malformations. CONCLUSIONS: The differences in regional deaths due to congenital malformations suggests specific risks that deserve further study.
Asunto(s)
Anomalías Congénitas/mortalidad , Adolescente , Adulto , Distribución por Edad , Anciano , Niño , Preescolar , Chile/epidemiología , Aberraciones Cromosómicas/mortalidad , Trastornos de los Cromosomas , Anomalías Congénitas/epidemiología , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Distribución por SexoRESUMEN
OBJECTIVES: The purpose of this study was to provide clinical and anatomical characteristics as well as genetic background of a malignant arrhythmogenic disorder. BACKGROUND: An inherited autosomally dominant cardiac syndrome causing stress-induced polymorphic ventricular tachycardia and syncope in the absence of structural myocardial changes was detected in two families. METHODS: Two unrelated families with six victims of sudden death and 51 living members were evaluated. Resting and exercise electrocardiograms (ECG), echocardiography, magnetic resonance imaging (MRI), cineangiography, microscopic examination of endomyocardial biopsies and a drug testing with a class IC antiarrhythmic agent flecainide were performed. A genetic linkage analysis was carried out to map the gene locus. RESULTS: Of the 24 affected individuals, 10 had succumbed with six cases of sudden death, and 14 survivors showed evidence of disease. Exercise stress test induced ventricular bigeminy or polymorphic ventricular tachycardia in affected individuals. Three children initially examined before 10 years of age developed arrhythmias during a four-year follow-up. Resting ECGs were normal in affected subjects except a slight prolongation of the QT intervals adjusted for heart rate (QTc) (430 +/- 18 vs. 409 +/- 19 ms, affected vs. nonaffected, p < 0.01). Administration of flecainide did not induce ECG abnormalities encountered in familial idiopathic ventricular fibrillation. Ventricular volumes, contractility and wall measurements were normal by echocardiography, right ventricular cineangiography and MRI. Histopathological examination showed no fibrosis or fatty infiltration. The cumulative cardiac mortality by the age of 30 years was 31%. The disease locus was assigned to chromosome 1q42-q43, with a maximal pairwise lod score of 4.74 in the two families combined. Only one heterozygous carrier was clinically unaffected suggesting high disease penetrance in adulthood. CONCLUSIONS: A distinct cardiac disorder linked to chromosome 1q42-q43 causes exercise-induced polymorphic ventricular tachycardia in structurally normal hearts and is highly malignant. Delayed clinical manifestation necessitates repeated exercise electrocardiography to assure diagnosis in young individuals of the families.
Asunto(s)
Aberraciones Cromosómicas/genética , Mapeo Cromosómico , Cromosomas Humanos Par 1/genética , Ligamiento Genético/genética , Miocardio/patología , Canales de Potasio de Dominio Poro en Tándem , Taquicardia Ventricular/genética , Adolescente , Adulto , Antiarrítmicos , Biopsia , Niño , Aberraciones Cromosómicas/diagnóstico , Aberraciones Cromosómicas/mortalidad , Trastornos de los Cromosomas , Cineangiografía , Angiografía Coronaria , Muerte Súbita Cardíaca/patología , Diagnóstico Diferencial , Ecocardiografía , Electrocardiografía , Prueba de Esfuerzo , Femenino , Flecainida , Humanos , Escala de Lod , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Contracción Miocárdica , Linaje , Canales de Potasio/genética , ARN/análisis , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Tasa de Supervivencia , Taquicardia Ventricular/diagnóstico , Taquicardia Ventricular/mortalidadRESUMEN
Cytogenetics provides important insights into the molecular pathogenesis of human cancers. Although extensive data exist on recurring cytogenetic abnormalities in hematologic cancers, data on individual solid tumor types remain limited. Previous studies of ovarian carcinoma indicated the presence of multiple, complex clonal chromosome abnormalities. Cytogenetics remains one of a few techniques capable of detecting these multiple, simultaneously occurring genetic abnormalities. We describe cytogenetic abnormalities from a series of 244 primary ovarian cancer specimens referred to a single institution. A total of 201/244 cases had fully characterized clonal chromosome abnormalities, of which 134 showed clonal chromosome breakpoints. We used a novel statistical technique to detect nonrandom chromosome breakpoints at the level of chromosome regions. Nonrandom occurrence of chromosome breakpoints was detected at regions 1p1*, 1q1*, 1p2*, 1q2*, 1p3*, 1q3, 3p1*, 1q4*, 6q1*, 6p2, 6q2, 7p1*, 7q1, 7p2*, 11p1*, 11q1, 11q2*, 12p1, 12q2*, 13p1, and 19q1. Simultaneous occurrence of multiple abnormalities was common. However, 120/134 cases had breakpoints at one or more of 13 commonly involved regions (*), suggesting a hierarchy of genetic abnormalities. Among clinical and tumor variables that predict patient survival, tumor grade was significantly associated with the presence of chromosome breakpoints. In additional studies, we show that nonrandom chromosome abnormalities are associated with impaired survival in ovarian cancer and that specific, nonrandomly involved chromosome regions retain significant effects on survival when analyses are controlled for important clinical variables. Additional specific chromosome abnormalities in this series are described, including chromosome gains and losses in near-diploid cases and homogeneously staining regions. These results suggest that recurring, nonrandom chromosome abnormalities are important in the pathogenesis and/or progression of ovarian cancers, and target areas of the genome for molecular genetic studies.
Asunto(s)
Adenocarcinoma/genética , Aberraciones Cromosómicas/genética , Neoplasias Ováricas/genética , Adenocarcinoma/mortalidad , Adulto , Anciano , Anciano de 80 o más Años , Aberraciones Cromosómicas/mortalidad , Rotura Cromosómica , Trastornos de los Cromosomas , Femenino , Estudios de Seguimiento , Amplificación de Genes , Humanos , Cariotipificación , Persona de Mediana Edad , Neoplasias Ováricas/mortalidad , Tasa de Supervivencia , Translocación GenéticaRESUMEN
As anormalidades cromossomicas constituem causas importantes de perda reprodutiva, malformacoes congenitas e retardo mental, alem de contribuirem de forma importante na morbi-mortalidade perinatal. Aproximadamente 15 porcento das gestacoes clinicamente reconhecidas na populacao terminam em aborto espontaneo e...
Asunto(s)
Humanos , Recién Nacido , Aberraciones Cromosómicas/mortalidad , Asesoramiento Genético , Mortalidad Infantil , Aberraciones Cromosómicas/diagnóstico , Aberraciones Cromosómicas/epidemiologíaRESUMEN
Tetrasomy 9p is a rare syndrome that has now been described in nearly a score of cases. We present a new case of i(9p) that presented to us early in infancy with significant dysmorphological features, including growth retardation, psycho-motor delay, hemifacial microsomia, auditory canal atresia, high-arched palate, bulbous nose, strabismus, epicanthic folds, congenital heart disease, dislocated hips, hypoplastic external genitalia, simian palmar creases, dysplastic nails and small digits. Chromosomal analysis revealed a 47,XX,idic(9)(q12) karyotype on GTG- and C-banding studies on peripheral blood lymphocytes. Fluorescent in situ hybridization (FISH) studies confirmed the origin of the extra chromosome. A review of the literature and a comparative analysis of the several well-documented cases of i(9p) revealed a pattern of recurring features, including ear malformations, skeletal and joint problems (especially dislocations), hypoplasia of nails and digits, palatal abnormalities, hypertelorism, urogenital anomalies and developmental retardation. In the light of this analysis, we feel that tetrasomy 9p will soon be considered a clinically recognizable syndrome.
Asunto(s)
Anomalías Múltiples/genética , Aneuploidia , Aberraciones Cromosómicas/genética , Cromosomas Humanos Par 9/genética , Anomalías Múltiples/mortalidad , Anomalías Múltiples/fisiopatología , Aberraciones Cromosómicas/mortalidad , Aberraciones Cromosómicas/fisiopatología , Trastornos de los Cromosomas , Anomalías Craneofaciales/genética , Anomalías Craneofaciales/fisiopatología , Femenino , Humanos , Hibridación Fluorescente in Situ , Recién Nacido , Discapacidad Intelectual/genética , Discapacidad Intelectual/fisiopatología , Cariotipificación , Masculino , Mosaicismo , Tasa de Supervivencia , SíndromeRESUMEN
OBJECTIVE: To review the outcomes of 193 fetuses with cardiac abnormalities detected by echocardiography. METHODS: A total of 422 fetuses between 16 and 41 gestational weeks, referred to paediatric cardiologists for detailed echocardiography, were included in this study. RESULTS: Structural heart defects were found in 55 (28%), isolated arrhythmia in 105 (54%), and other non-structural abnormalities (dilated cardiomyopathy, hypertrophic cardiomyopathy, aneurysm of the foramen ovale, isolated pericardial effusion or echogenic foci) in 33 (17%) of 193 fetuses. Total mortality was 26%. The prognosis was poor in fetuses with structural heart defects; 37 of 55 cases (67%) died in utero or postnatally. Chromosomal abnormality was associated with structural heart defect in 38% of fetuses, of whom 38% died. Among fetuses with isolated arrhythmia survival was 95%. Poor outcome was associated with complete heart block (n = 14) in 2 (14%) fetuses with hydrops and heart rate of less than 55 per minute, and with supraventricular tachycardia (n = 21) in three (14%) neonates delivered prematurely at a mean gestational age of 33 weeks. Furthermore, nine of 12 fetuses (75%) with structural heart defects and arrhythmia died. Among fetuses with non-structural cardiac abnormalities, survival was 73%. Poor outcome was evident in fetuses with dilated cardiomyopathy in eight of 13 (62%) and with hypertrophic cardiomyopathy in one of eight (13%) of cases. CONCLUSIONS: Factors associated with a poor prognosis were: structural heart defect associated with chromosomal abnormality or arrhythmia, congestive heart failure associated with supraventricular tachycardia or complete heart block, especially if delivery occurs preterm; and fetal hydrops with congestive heart failure and atrioventricular valve regurgitation.
Asunto(s)
Arritmias Cardíacas/diagnóstico por imagen , Ecocardiografía Doppler , Enfermedades Fetales/diagnóstico por imagen , Cardiopatías Congénitas/diagnóstico por imagen , Resultado del Embarazo , Ultrasonografía Prenatal , Arritmias Cardíacas/complicaciones , Arritmias Cardíacas/mortalidad , Aberraciones Cromosómicas/mortalidad , Trastornos de los Cromosomas , Femenino , Enfermedades Fetales/mortalidad , Bloqueo Cardíaco/complicaciones , Bloqueo Cardíaco/diagnóstico por imagen , Bloqueo Cardíaco/mortalidad , Cardiopatías Congénitas/complicaciones , Cardiopatías Congénitas/mortalidad , Insuficiencia Cardíaca/complicaciones , Insuficiencia Cardíaca/diagnóstico por imagen , Insuficiencia Cardíaca/mortalidad , Humanos , Hidropesía Fetal/complicaciones , Hidropesía Fetal/diagnóstico por imagen , Hidropesía Fetal/mortalidad , Recién Nacido , Embarazo , Segundo Trimestre del Embarazo , Tercer Trimestre del EmbarazoRESUMEN
This retrospective multicenter study represents an analysis of the intrauterine determinants of the prognosis for conotruncal anomalies. Data regarding reason for referral, presence of chromosomal or extracardiac anomalies, pregnancy and surgical outcome were recorded in 67 cases of conotruncal anomalies from three Italian referral units. Chromosomal aberrations effected 11 of the 60 (18.3%) fetuses in which a karyotype was available. Extra-cardiac malformations were present in 25/67 cases (37.3%). No chromosomal anomalies were present in fetuses with complete or corrected transposition of the great arteries. However, tetralogy of Fallot and double-outlet right ventricle were associated with chromosomal anomalies in 22% and 38% of cases, respectively, and with extracardiac anomalies in 45% and 46% of cases, respectively. Only 20 of the 67 (31%) cardiac malformations were associated with an abnormal four-chamber view. There were 28 (41.7%) terminations of pregnancy, six (8.9%) intrauterine deaths and 16 (23.8%) neonatal deaths. Seventeen neonates (25.3%) are currently alive, and 15 of these have undergone reparative surgery. The prognosis of conotruncal anomalies is poorer when the conditions is diagnosed in utero. This is mainly due to the frequent association with chromosomal and/or extracardiac anomalies, often leading to intrauterine or early neonatal death.
Asunto(s)
Aberraciones Cromosómicas/diagnóstico , Ecocardiografía/métodos , Cardiopatías Congénitas/diagnóstico por imagen , Ultrasonografía Prenatal/métodos , Aberraciones Cromosómicas/genética , Aberraciones Cromosómicas/mortalidad , Trastornos de los Cromosomas , Femenino , Edad Gestacional , Cardiopatías Congénitas/genética , Cardiopatías Congénitas/mortalidad , Humanos , Italia , Cariotipificación , Embarazo , Resultado del Embarazo , Pronóstico , Estudios Retrospectivos , Sensibilidad y Especificidad , Tasa de SupervivenciaRESUMEN
Pericardial sac samples from 77 bovine aborted fetuses and stillborn calves were submitted for tissue culture; cells from 55 of these samples were grown successfully in culture. Six of the 55 karyotyped fetuses (10.7%) had an abnormal chromosome complement, in 3 of which (5.5%) the abnormality was probably the cause of death. This level of abnormality is relatively high when one considers that most fetuses were >8 months gestational age. Approximately 5-7% of human stillbirths and 50% of first-trimester aborted fetuses have chromosome anomalies. If a similar situation exists in cattle, as suggested by these data, chromosome abnormalities may be a major cause of early fetal loss in cattle. Most chromosomally abnormal fetuses had multiple malformations, which suggests that the diagnostic use of chromosome analysis is most cost effective for malformed fetuses and newborns. Twins were present in a higher proportion of these fetuses than expected based on their incidence among liveborn cattle.
Asunto(s)
Aborto Veterinario/genética , Aneuploidia , Enfermedades de los Bovinos/genética , Aberraciones Cromosómicas/veterinaria , Animales , Animales Recién Nacidos , Bovinos , Aberraciones Cromosómicas/genética , Aberraciones Cromosómicas/mortalidad , Trastornos de los Cromosomas , Femenino , Muerte Fetal , Humanos , Cariotipificación , Masculino , Embarazo , Especificidad de la EspecieRESUMEN
OBJECTIVE: To review the clinical features, associated congenital abnormalities, management, and morbidity of infants presenting with posterior laryngeal and laryngotracheal clefts. DESIGN: Case series. SETTING: Great Ormond Street Hospital for Sick Children NHS Trust, London, England. PATIENTS: Consecutive sample of 44 patients presenting with posterior laryngeal and laryngotracheal clefts between December 10, 1979, and January 30, 1992. MAIN OUTCOME MEASURES: Clinical features, incidence of surgery, and associated morbidity and mortality related to different types of airway cleft. RESULTS: The main presenting features were stridor and aspiration, which were more evident with the more extensive clefts. Twenty-five patients (56%) had associated congenital abnormalities. Fourteen patients (32%) were treated conservatively. Sixteen patients (36%) underwent primary endoscopic surgical repair. Eight patients (18%) underwent primary repair via an anterior laryngofissure; and six patients (14%) underwent primary repair via a lateral pharyngotomy. Eight patients (18%) required revision surgery, two (4%) of them on more than one occasion. Ten patients (23%) required fundoplication to control gastroesophageal reflux. Six patients (14%) died. CONCLUSIONS: The identification of an airway cleft requires a high index of suspicion. Morbidity and mortality are reduced by securing the airway, controlling gastroesophageal reflux, and using a multidisciplinary pediatric team. We recommend the anterior laryngofissure because of the ease of surgical access.
Asunto(s)
Esófago/anomalías , Laringe/anomalías , Tráquea/anomalías , Anomalías Múltiples/diagnóstico , Anomalías Múltiples/mortalidad , Anomalías Múltiples/cirugía , Causas de Muerte , Aberraciones Cromosómicas/diagnóstico , Aberraciones Cromosómicas/mortalidad , Trastornos de los Cromosomas , Esófago/cirugía , Humanos , Laringe/cirugía , Ruidos Respiratorios/diagnóstico , Tráquea/cirugíaRESUMEN
OBJECTIVES: To determine the percentage of patients dying in the pediatric intensive care unit (PICU) who have heritable disorders and to compare vital statistics classification of underlying cause of death with underlying heritable disorder identified from medical record review. DESIGN: Retrospective medical record review. SETTING: The PICU of a university-affiliated hospital. METHODS: Medical records were reviewed for all deaths occurring in the PICA over a 5-year period. Further review, including hospital course, clinical findings, and the presence or absence of a genetic evaluation, was accomplished for those patients found to have a chromosome abnormality, recognized syndrome, single major malformation, or unrecognized syndrome. Underlying cause of death classification obtained from the Center for Health Statistics, Arkansas Department of Health was reviewed to determine the frequency with which the underlying heritable disorder was recorded. RESULTS: Fifty-one of 268 (19%) deaths during the study period were in patients with heritable disorders. Of these 51 patients, eight (16%) had chromosome abnormalities, 17 (33%) had a recognized syndrome, 15 (29%) had a single primary defect in development, and 11 (22%) had an unrecognized syndrome. Genetic evaluation was carried out on 45% of patients, with the frequency of evaluation differing between categories of patients with heritable conditions. When underlying cause of death from vital statistics classification was reviewed, 21 of 51 (41%) records did not include the underlying heritable disorder. CONCLUSIONS: Heritable disorders are a frequent cause of mortality in the PICU. Vital statistics classification of underlying cause of death in this population often fails to identify heritable disorders, leading to an underascertainment of these conditions in mortality statistics. Improved cause of death classification procedures will be necessary to target public health interventions to etiology-specific populations.
Asunto(s)
Anomalías Congénitas/mortalidad , Enfermedades Genéticas Congénitas/mortalidad , Mortalidad Hospitalaria , Unidades de Cuidado Intensivo Pediátrico , Preescolar , Aberraciones Cromosómicas/mortalidad , Trastornos de los Cromosomas , Comorbilidad , Humanos , SíndromeRESUMEN
The aim of the study was to determine the outcome of fetuses with non-immune hydrops (NIH) following modern invasive investigation and therapy. This prospectively planned observational study involved 23 women with singleton fetuses in whom a diagnosis of NIH was made in our fetal medicine unit in 1 year. After investigation and counselling 15 of the 23 women opted for termination of pregnancy (10 chromosomal and 5 structural abnormalities) and there was 1 intrauterine fetal death before therapy was attempted. One case with diaphragmatic hernia was treated with shunting which successfully reversed the hydrops, the pregnancy continued to term, the malformation was surgically corrected but the neonate died from pulmonary hypoplasia. In the remaining 6 cases structural and chromosomal abnormalities were excluded. One had amniotic fluid drainage for polyhydramnios but despite this delivered at 30 weeks' gestation and the neonate died on day 5. The remaining 5 cases had fetal therapy between 22 and 32 weeks' gestation (4 shunt insertions, 1 blood transfusion) and in all the hydrops reversed and the pregnancy continued to at least 35 weeks' gestation. All 5 neonates were discharged from hospital alive and well. Fetal therapy in cases of NIH with normal structure and karyotype was associated with a very good outcome. Giving a uniform poor prognosis is no longer justified because if other fetal abnormalities are excluded, in utero treatment, reversal of the hydrops and survival are often possible. We recommend urgent referral of these cases to a fetal medicine unit.
Asunto(s)
Aberraciones Cromosómicas/mortalidad , Enfermedades Fetales/mortalidad , Viabilidad Fetal , Feto/anomalías , Hidropesía Fetal/mortalidad , Adolescente , Adulto , Recuento de Células , Trastornos de los Cromosomas , Femenino , Muerte Fetal , Enfermedades Fetales/terapia , Humanos , Hidropesía Fetal/terapia , Cariotipificación , Linfocitos/citología , Derrame Pleural/citología , Embarazo , Pronóstico , Resultado del TratamientoRESUMEN
In order to determine the frequency of associated malformations and chromosomal defects in patients with congenital diaphragmatic hernia (CDH) our experiences with CDH during the last 8 years (1985-1993) were reviewed. During the study period, 33 fetuses (prenatal group) with CDH were examined at our level III ultrasound department. In the same period 11 neonates (postnatal group) were admitted to our pediatric surgical unit after postnatal diagnosis of a CDH. Those cases had not been suspicious for CDH during prenatal level I scan. In 24 (72.7%) of the cases with CDH seen prenatally, at least one or more extradiaphragmatic malformations could be detected. Most of them affected the cardiovascular, skeletal, genitourinary and nervous system. Six (18.1%) fetuses had chromosomal abnormalities, especially trisomy 18. In contrast to these findings just 4 of the 11 babies (36.3%) seen postnatally had associated malformations and all of them had a normal chromosome set. Survival rate of fetuses with CDH and associated anomalies (7.1%) was poor, in contrast to those with an isolated CDH (43.7%). Prenatal ultrasound investigations being suspect for CDH should encourage the clinician to make further diagnostical efforts. This includes detailed ultrasound examination and cytogenetic analysis. Associated malformations as well as chromosomal defects are often present in affected patients.
Asunto(s)
Anomalías Múltiples/genética , Aberraciones Cromosómicas/genética , Hernias Diafragmáticas Congénitas , Anomalías Múltiples/diagnóstico por imagen , Anomalías Múltiples/mortalidad , Aberraciones Cromosómicas/mortalidad , Trastornos de los Cromosomas , Femenino , Hernia Diafragmática/diagnóstico por imagen , Hernia Diafragmática/genética , Hernia Diafragmática/mortalidad , Humanos , Lactante , Recién Nacido , Embarazo , Diagnóstico Prenatal , Estudios Retrospectivos , Tasa de Supervivencia , Ultrasonografía PrenatalRESUMEN
To determine the diagnostic and/or prognostic importance of chromosomal aberrations identified in dogs with malignant (non-Hodgkin's) lymphoma, clinical stages for 61 dogs with lymphosarcoma were determined, the lymph node(s) were histopathologically graded, and the malignant tissue lymphocytes were karyotyped. The results from life table survival curve analysis demonstrated that first remission length and survival time were significantly longer in 15 of 61 (25%) dogs that had a trisomy of chromosome 13 as the primary chromosomal aberration than in those dogs (46/61, 75%) with other primary chromosomal aberrations (P < 0.05). Sex, age, weight, histopathologic subtype and grade, World Health Organization (WHO) clinical stage, WHO and modified Karnofsky performance status, chromosomal modal number, and treatment protocol were of no prognostic importance in predicting first remission length or survival time (P > 0.05). Multivariate analysis did not identify a significant correlation between the prognostic groups or within the various prognostic subsets (P > 0.05). The pathogenesis of canine and human non-Hodgkin's lymphoma, as observed cytogenetically, differs.
Asunto(s)
Aberraciones Cromosómicas/veterinaria , Enfermedades de los Perros/genética , Linfoma no Hodgkin/veterinaria , Animales , Aberraciones Cromosómicas/genética , Aberraciones Cromosómicas/mortalidad , Trastornos de los Cromosomas , Enfermedades de los Perros/mortalidad , Enfermedades de los Perros/patología , Perros , Femenino , Cariotipificación , Linfoma no Hodgkin/genética , Linfoma no Hodgkin/mortalidad , Linfoma no Hodgkin/patología , Masculino , Estadificación de Neoplasias , Pronóstico , Estudios Prospectivos , Inducción de Remisión , Tasa de SupervivenciaRESUMEN
We examined the contribution of chromosomal abnormalities, mendelian disorders, and birth defects to mortality in a regional neonatal intensive care unit by medical record review of neonatal deaths in that unit. Of a total of 296 infant deaths during the 5-year period June 1986 to May 1991, 69 (23.3%) had a genetic disorder. By diagnostic category, 18.8% had a chromosomal abnormality, 10.1% had a mendelian condition, 42% had a single primary defect in development, and 29% had an unrecognized pattern of malformation. The rate of autopsy and genetic evaluation differed markedly between these diagnostic categories. A comparison was made of underlying cause of death determined from medical records with underlying cause as classified by vital statistics nosologic procedures. No death certificate was on file for two of the deaths; for the remaining 67, 27 (40.3%) had an erroneous or misleading underlying cause of death as determined from vital statistics. The important contribution of genetic disorders to neonatal mortality in this high-risk population and the relative underrecognition of these disorders by vital statistics sources indicate that efforts aimed at reducing neonatal mortality will require a full range of preventive health activities, including preconception, prenatal and perinatal assessment, and counseling. Improved data collection techniques need to be developed to understand the contribution of this group of conditions to total neonatal mortality.
Asunto(s)
Causas de Muerte , Aberraciones Cromosómicas/mortalidad , Anomalías Congénitas/mortalidad , Trastornos de los Cromosomas , Mortalidad Hospitalaria , Humanos , Lactante , Mortalidad Infantil , Recién Nacido , Unidades de Cuidado Intensivo NeonatalRESUMEN
Prenatal diagnosis of trisomy 18 by amniocentesis in the latter half of pregnancy is now a common event. Accurate prognostic information is crucial for families making decisions about delivery management. Three recently published studies showed much shorter survival for trisomy 18 than was reported by earlier papers. For this reason, we studied trisomy 18 survival. We examined chromosome laboratory records to find all trisomy 18 diagnoses made in Utah between 1979 and 1988. Death certificates and hospital records were used to determine survival. We found 64 liveborn cases with trisomy 18 out of 388,563 total births over the 10-year period, a prevalence of 1/6071. Our results show a median survival of 4 days and a 1 week survival of 45%, similar to that reported in the 3 recent studies. However, we had a significantly greater survival at 6 months (9% in Utah versus 3% in Denmark) and 1 year (5% versus 0 in the 3 studies). In contrast to recent studies, earlier investigations showed 80% survival at 2 weeks and 8% at 1 year. It is not surprising that recent studies show shorter survival, since in the 1960s the diagnosis was typically not made until age 2 months. With prenatal and neonatal diagnosis many cases which would have died prior to detection in earlier times are now diagnosed. The longer survival discrepancies are more difficult to explain, but may simply be due to small numbers.
Asunto(s)
Anomalías Múltiples/mortalidad , Aberraciones Cromosómicas/mortalidad , Cromosomas Humanos Par 18 , Trisomía/fisiopatología , Niño , Preescolar , Trastornos de los Cromosomas , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Prevalencia , Factores Sexuales , Tasa de Supervivencia , Utah/epidemiologíaRESUMEN
The natural history of trisomy 18 and trisomy 13 was investigated using data derived from parent questionnaires and medical records from 98 families with an index case of trisomy 18 and 32 families with an index case of trisomy 13. Data are presented on pregnancy, delivery, survival, medical complications, immunizations, growth, cause of death, cytogenetics, and recurrence risk. Half of the trisomy 18 babies were delivered by C-section. Fetal distress was a factor in half, and the only reason in a third of C-section deliveries. One minute Apgar scores were significantly lower in C-section and breech deliveries. There were more small for gestational age babies than in the general population, but most of the low birth weight newborns were small for gestational age, unlike the general population. Survival in this group of children was better than in other studies due to ascertainment bias. There were more girls than boys at all ages for both conditions, and the sex ratio decreased with time. Growth curves for length, weight, head circumference, and weight vs height are provided. Long-term survival did not appear to be due to mosaicism. We found no adverse reactions attributable to immunizations. At age 1 year there was an average of approximately 2 operations per living child. We report the second case of successful major cardiac surgery in a trisomy 18 child. Almost 70% of deaths were attributed to cardiopulmonary arrest. The sibling recurrence risk for trisomy 18 or trisomy 13 was 0.55%.
Asunto(s)
Anomalías Múltiples/fisiopatología , Aberraciones Cromosómicas/fisiopatología , Cromosomas Humanos Par 13 , Cromosomas Humanos Par 18 , Trisomía/fisiopatología , Anomalías Múltiples/mortalidad , Anomalías Múltiples/patología , Puntaje de Apgar , Causas de Muerte , Niño , Preescolar , Aberraciones Cromosómicas/mortalidad , Aberraciones Cromosómicas/patología , Trastornos de los Cromosomas , Parto Obstétrico , Salud de la Familia , Femenino , Retardo del Crecimiento Fetal , Paro Cardíaco , Humanos , Lactante , Recién Nacido , Masculino , Embarazo , Complicaciones del Embarazo , Análisis de Regresión , Estudios Retrospectivos , Factores de Riesgo , Razón de Masculinidad , Encuestas y Cuestionarios , Tasa de Supervivencia , Trisomía/genética , Trisomía/patologíaRESUMEN
Cytogenetic studies with high-resolution banding were performed on specimens from 132 consecutive patients with de novo acute myeloid leukemia (AML). All patients were treated according to therapeutic protocols in the same institution. Clonal abnormalities were detected in 97 of the 124 patients in whom an adequate number of mitoses was obtained (78.2%). Neither sex, FAB classification, WBC, or the extent of bone marrow infiltrate affected the rate of chromosomal aberrations, whereas patients younger than 40 years had a greater proportion of normal karyotypes (p = 0.047). Two different chromosomal classifications were evaluated: the presence of normal and abnormal metaphases (NN-AN-AA classification), and a classification in cytogenetic categories, the latter being based on the frequency of cytogenetic abnormalities. Both classifications were found to correlate significantly with the clinical outcome. They also showed independent prognostic significance when age, sex, and FAB morphology were considered in a multivariate analysis. Two abnormalities were closely associated with specific clinical-pathologic subsets of AML. All the 15 patients with t(15;17) had acute promyelocytic leukemia; this translocation was not found in any other subset of AML. Eight of the nine patients presenting rearrangements at 11q23 belonged to a FAB subset with monocytic differentiation (M4 and M5). Our data suggest that cytogenetic findings should influence the therapeutic approach to AML. In particular, young patients with karyotypes associated with poor responses may be considered for more eradicating treatments, including allogenic bone marrow transplantation.